Back to Search Start Over

Acadesine (Acadra‘) for Patients with Resistant/Relapsed Chronic B-Cell Lymphocytic Leukemia (B-CLL): A Multicentre Phase I/II Study.

Authors :
Van Den Neste, Eric W
Gonzalez-Barca, Eva
Janssens, Ann
Cazin, Bruno
de Oteyza, J. Pérez
Terol, Maria Jose
Auton, T.
Saunders, Andrew
Campas, Clara
Source :
Blood; November 2009, Vol. 114 Issue: 22 p4405-4405, 1p
Publication Year :
2009

Abstract

Off Label Use: Acadesine (AcadraTM): nucleoside that induces cell death in B-cell chronic lymphocytic leukemia.. Auton:BTG Limited: Consultancy; Advancell Technologies Inc.: Consultancy. Saunders:BTG limited: Consultancy; Advancell Technologies: Consultancy. Campas:Advancecell Technologies Inc: Employment, Equity Ownership.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
114
Issue :
22
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs52973007
Full Text :
https://doi.org/10.1182/blood.V114.22.4405.4405